Peter Malfertheiner

Prof emeritus

Klinikum der Universität München

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Microbiology Microbiology professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Peter Malfertheiner is a Professor Emeritus at Klinikum der Universität München in Germany. His research primarily focuses on Helicobacter pylori and its implications in gastric cancer prevention and diagnosis. He has contributed significantly to the understanding of probiotic effects on H. pylori and the development of antimicrobial susceptibility testing. His recent publications reflect a commitment to advancing knowledge in digestive diseases and the management of H. pylori infections.

Articles (18)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (5)

Shailja Shah

University of California, San Diego

UNITED STATES

View details

MASSIMO RUGGE

Professor of Pathology

University of Padova

ITALY

View details

Christiane K. Kuhl

University Hospital RWTH Aachen

GERMANY

View details

Osman Öcal

Klinikum der Universität München

GERMANY

View details

Emad El-Omar

Professor of Medicine

University of New South Wales

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Peter Malfertheiner

Research Interests

Explore related searches

Contact this professor

About

Articles (18)

Screening and eradication of Helicobacter pylori for gastric cancer prevention: Taipei Global Consensus II

Ways to improve the negative impact of proton pump inhibitors on biopsy-based test accuracy for Helicobacter pylori detection

40 Years of Digestive Diseases

In vivo Inhibition of Helicobacter pylori through Probiotics and Gastrointestinal Commensals: A Critical Review

Inhibitory Effects of Probiotic and Gastro-Intestinal Bacteria on Helicobacter pylori in vitro

Editorial: Helicobacter pylori Antimicrobial Susceptibility Testing—An Expanding Toolbox. Authors' Reply

Real‐Time Assessment of H. pylori Infection to Guide Molecular Antibiotic Resistance Testing: A Combined Endoscopy‐Gastric Juice Analysis Approach

Development and External Validation of the Munich Sorafenib Evaluation Score for Hepatocellular Carcinoma

Atrophic autoimmune gastritis: ‘a muddled or misguided core concept compromises our overall comprehension of the problem’

Gastric cancer risk in autoimmune gastritis: evidence versus opinion

Helicobacter pylori infection

Empiric use of standard triple therapy inHelicobacter pylorieradication does not require readjustment in the clarithromycin resistance cut-off point

Editorial: PPIs and gastric cancer–Are we dealing with a carcinogen?

Letter to the editor:Helicobacter pylorieradication – the proof is not in the symptoms

Extracellular Vesicles May Predict Response to Radioembolization and Sorafenib Treatment in Advanced Hepatocellular Carcinoma: An Exploratory Analysis from the SORAMIC Trial

Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report

The Fear of Gastric Cancer in Patients with Dyspepsia: Challenge in Specialist Care Gastroenterology

Severe cases of sprue‐like enteropathy associated with angiotensin receptor blockers other than olmesartan

Collaborators (5)

Shailja Shah

MASSIMO RUGGE

Christiane K. Kuhl

Osman Öcal

Emad El-Omar

Make your next move.